Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy

Kerry A. Morrison, Ulrich P. Jorde, Arthur R. Garan, Hiroo Takayama, Yoshifumi Naka, Nir Uriel

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The Levitronix CentriMag is a magnetically levitated centrifugal-flow pump that can be implanted rapidly in the operating room for both right and left ventricular support. Recently, continuous-flow pumps have been associated with excessive bleeding, which can be at least partially explained by acquired von Willebrand disease (vWD). We investigated whether acquired vWD occurs during CentriMag support and determined the frequency of bleeding complications during device support as well as after transition to long-term support. We found that acquired vWD is common early post CentriMag implantation and is associated with frequent bleeding events and high requirement of blood products.

Original languageEnglish (US)
Pages (from-to)241-242
Number of pages2
JournalASAIO Journal
Volume60
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

von Willebrand Diseases
Hemorrhage
Pumps
Operating rooms
Operating Rooms
Blood
Therapeutics
Equipment and Supplies

Keywords

  • Acquired von Willebrand
  • Bleeding
  • CentriMag
  • Heart replacement therapy
  • Ventricular assist device

ASJC Scopus subject areas

  • Biophysics
  • Biomaterials
  • Bioengineering
  • Biomedical Engineering
  • Medicine(all)

Cite this

Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy. / Morrison, Kerry A.; Jorde, Ulrich P.; Garan, Arthur R.; Takayama, Hiroo; Naka, Yoshifumi; Uriel, Nir.

In: ASAIO Journal, Vol. 60, No. 2, 2014, p. 241-242.

Research output: Contribution to journalArticle

@article{27e9bef832fb4e34888ae2aed8f31285,
title = "Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy",
abstract = "The Levitronix CentriMag is a magnetically levitated centrifugal-flow pump that can be implanted rapidly in the operating room for both right and left ventricular support. Recently, continuous-flow pumps have been associated with excessive bleeding, which can be at least partially explained by acquired von Willebrand disease (vWD). We investigated whether acquired vWD occurs during CentriMag support and determined the frequency of bleeding complications during device support as well as after transition to long-term support. We found that acquired vWD is common early post CentriMag implantation and is associated with frequent bleeding events and high requirement of blood products.",
keywords = "Acquired von Willebrand, Bleeding, CentriMag, Heart replacement therapy, Ventricular assist device",
author = "Morrison, {Kerry A.} and Jorde, {Ulrich P.} and Garan, {Arthur R.} and Hiroo Takayama and Yoshifumi Naka and Nir Uriel",
year = "2014",
doi = "10.1097/MAT.0000000000000049",
language = "English (US)",
volume = "60",
pages = "241--242",
journal = "ASAIO journal (American Society for Artificial Internal Organs : 1992)",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy

AU - Morrison, Kerry A.

AU - Jorde, Ulrich P.

AU - Garan, Arthur R.

AU - Takayama, Hiroo

AU - Naka, Yoshifumi

AU - Uriel, Nir

PY - 2014

Y1 - 2014

N2 - The Levitronix CentriMag is a magnetically levitated centrifugal-flow pump that can be implanted rapidly in the operating room for both right and left ventricular support. Recently, continuous-flow pumps have been associated with excessive bleeding, which can be at least partially explained by acquired von Willebrand disease (vWD). We investigated whether acquired vWD occurs during CentriMag support and determined the frequency of bleeding complications during device support as well as after transition to long-term support. We found that acquired vWD is common early post CentriMag implantation and is associated with frequent bleeding events and high requirement of blood products.

AB - The Levitronix CentriMag is a magnetically levitated centrifugal-flow pump that can be implanted rapidly in the operating room for both right and left ventricular support. Recently, continuous-flow pumps have been associated with excessive bleeding, which can be at least partially explained by acquired von Willebrand disease (vWD). We investigated whether acquired vWD occurs during CentriMag support and determined the frequency of bleeding complications during device support as well as after transition to long-term support. We found that acquired vWD is common early post CentriMag implantation and is associated with frequent bleeding events and high requirement of blood products.

KW - Acquired von Willebrand

KW - Bleeding

KW - CentriMag

KW - Heart replacement therapy

KW - Ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=84896382660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896382660&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000049

DO - 10.1097/MAT.0000000000000049

M3 - Article

VL - 60

SP - 241

EP - 242

JO - ASAIO journal (American Society for Artificial Internal Organs : 1992)

JF - ASAIO journal (American Society for Artificial Internal Organs : 1992)

SN - 1058-2916

IS - 2

ER -